Vir Biotechnology (VIR) Amortization - Intangibles (2020 - 2024)

Vir Biotechnology has disclosed Amortization - Intangibles across 5 years of filings, most recently posting $18.8 million for Q2 2024.

• Amortization - Intangibles for Q2 2024 came in at $18.8 million, down 18.12% year-over-year; the trailing twelve-month figure through Jun 2024 was $82.8 million (up 18.57% YoY), and the FY2023 annual result was $87.0 million, up 209.66% from the prior year.
• Amortization - Intangibles came in at $18.8 million for Q2 2024 at Vir Biotechnology, down from $21.3 million in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $23.0 million in Q2 2023 to a low of $11000.0 in Q3 2021.
• The 5-year median for Amortization - Intangibles is $2.0 million (2020), against an average of $8.8 million.
• Across the five-year window, Amortization - Intangibles tumbled 97.33% in 2021 and surged 84736.36% in 2022, its largest moves.
• Vir Biotechnology's Amortization - Intangibles stood at $288000.0 in 2020, then sank by 42.01% to $167000.0 in 2021, then surged by 9583.83% to $16.2 million in 2022, then grew by 28.22% to $20.7 million in 2023, then dropped by 9.11% to $18.8 million in 2024.
• The last three Amortization - Intangibles figures came in at $18.8 million (Q2 2024), $21.3 million (Q1 2024), and $20.7 million (Q4 2023), per Business Quant data.